Fall Clinical News: Tapinarof Cream, 1% Maintains High Rate of Complete Clearance in Adults and Kids With AD
Tapinarof cream, 1% (Vtama, Dermavant) demonstrated a high rate of complete disease clearance in atopic dermatitis (AD), with more than half of enrolled adults and children entering with or achieving a Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) score of zero at least once, on monotherapy, according to the ADORING 3 open-label, long-term extension […]